These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36943057)

  • 1. RISING STARS: Targeting G protein-coupled receptors to regulate energy homeostasis.
    Jamaluddin A; Gorvin CM
    J Mol Endocrinol; 2023 May; 70(4):. PubMed ID: 36943057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptors in energy homeostasis.
    Wang J; Xiao R
    Sci China Life Sci; 2014 Jul; 57(7):672-80. PubMed ID: 24969703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes.
    Bjenning C; Al-Shamma H; Thomsen W; Leonard J; Behan D
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1051-62. PubMed ID: 15535426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors.
    Piper NBC; Whitfield EA; Stewart GD; Xu X; Furness SGB
    Biochem Pharmacol; 2022 Aug; 202():115115. PubMed ID: 35671790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.
    Izaguirre M; Gil MJ; Monreal I; Montecucco F; Frühbeck G; Catalán V
    Curr Diab Rep; 2017 Jun; 17(6):43. PubMed ID: 28451950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptors as targets for anti-diabetic therapeutics.
    Oh DY; Olefsky JM
    Nat Rev Drug Discov; 2016 Mar; 15(3):161-72. PubMed ID: 26822831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus.
    Liu T; Ji RL; Tao YX
    Pharmacol Ther; 2022 Jun; 234():108044. PubMed ID: 34822948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G Protein-Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus.
    Riddy DM; Delerive P; Summers RJ; Sexton PM; Langmead CJ
    Pharmacol Rev; 2018 Jan; 70(1):39-67. PubMed ID: 29233848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal bile acid receptors are key regulators of glucose homeostasis.
    Trabelsi MS; Lestavel S; Staels B; Collet X
    Proc Nutr Soc; 2017 Aug; 76(3):192-202. PubMed ID: 27846919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes.
    Barella LF; Jain S; Kimura T; Pydi SP
    FEBS J; 2021 Apr; 288(8):2622-2644. PubMed ID: 33682344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR55: from orphan to metabolic regulator?
    Liu B; Song S; Jones PM; Persaud SJ
    Pharmacol Ther; 2015 Jan; 145():35-42. PubMed ID: 24972076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein-coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives.
    Sebastiani G; Ceccarelli E; Castagna MG; Dotta F
    Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):201-213. PubMed ID: 29678286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.
    Elvert R; Herling AW; Bossart M; Weiss T; Zhang B; Wenski P; Wandschneider J; Kleutsch S; Butty U; Kannt A; Wagner M; Haack T; Evers A; Dudda A; Lorenz M; Keil S; Larsen PJ
    Diabetes Obes Metab; 2018 Aug; 20(8):1836-1851. PubMed ID: 29938884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel advances in understanding fatty acid-binding G protein-coupled receptors and their roles in controlling energy balance.
    Tian M; Wu Z; Heng J; Chen F; Guan W; Zhang S
    Nutr Rev; 2022 Jan; 80(2):187-199. PubMed ID: 34027989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory roles of G-protein coupled receptors in adipose tissue metabolism and their therapeutic potential.
    Im H; Park JH; Im S; Han J; Kim K; Lee YH
    Arch Pharm Res; 2021 Feb; 44(2):133-145. PubMed ID: 33550564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid receptors as new therapeutic targets for diabetes.
    Rayasam GV; Tulasi VK; Davis JA; Bansal VS
    Expert Opin Ther Targets; 2007 May; 11(5):661-71. PubMed ID: 17465724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled receptors as regulators of energy homeostasis.
    Tao YX; Yuan ZH; Xie J
    Prog Mol Biol Transl Sci; 2013; 114():1-43. PubMed ID: 23317781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
    Chávez-Talavera O; Tailleux A; Lefebvre P; Staels B
    Gastroenterology; 2017 May; 152(7):1679-1694.e3. PubMed ID: 28214524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of incretins on energy homeostasis: physiology and implications for the treatment of type 2 diabetes mellitus and obesity.
    Karras S; Goulis DG; Mintziori G; Katsiki N; Tzotzas T
    Curr Vasc Pharmacol; 2012 Nov; 10(6):781-91. PubMed ID: 22272906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.